Globe Life (NYSE:GL) Sets New 12-Month High – Should You Buy?

Globe Life Inc. (NYSE:GL)’s share price hit a new 52-week high on Thursday . The company traded as high as $183.94 and last traded at $183.5960, with a volume of 23496 shares traded. The stock had previously closed at $181.51.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Keefe, Bruyette & Woods increased their price target on shares of Globe Life from $180.00 to $192.00 and gave the stock an “outperform” rating in a research report on Monday. Wells Fargo & Company upped their target price on Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. Weiss Ratings raised Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. TD Cowen lifted their price target on Globe Life from $199.00 to $215.00 and gave the company a “buy” rating in a research note on Tuesday, June 23rd. Finally, Truist Financial boosted their price target on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $184.60.

Globe Life Trading Up 1.0%

The business’s fifty day moving average is $165.24 and its 200-day moving average is $151.01. The firm has a market cap of $14.23 billion, a P/E ratio of 12.68 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the firm earned $3.07 earnings per share. The company’s revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Analysts predict that Globe Life Inc. will post 15.64 EPS for the current year.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Monday, July 6th. Globe Life’s payout ratio is 9.13%.

Insider Transactions at Globe Life

In other news, CFO Thomas Peter Kalmbach sold 7,936 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.59, for a total value of $1,242,698.24. Following the completion of the sale, the chief financial officer owned 50,496 shares of the company’s stock, valued at approximately $7,907,168.64. This represents a 13.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Cheryl Alston sold 8,258 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the transaction, the director owned 16,621 shares of the company’s stock, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 124,187 shares of company stock worth $19,529,414. 2.11% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of GL. Compound Planning Inc. lifted its stake in Globe Life by 4.3% during the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after acquiring an additional 82 shares in the last quarter. Root Financial Partners LLC grew its stake in shares of Globe Life by 23.3% in the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock worth $61,000 after acquiring an additional 83 shares in the last quarter. Transcend Capital Advisors LLC grew its stake in shares of Globe Life by 3.9% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after acquiring an additional 84 shares in the last quarter. Natural Investments LLC raised its holdings in shares of Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after purchasing an additional 87 shares during the last quarter. Finally, Parallel Advisors LLC raised its holdings in shares of Globe Life by 5.6% in the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after purchasing an additional 87 shares during the last quarter. 81.61% of the stock is owned by institutional investors.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.